The standards
Does it apply to you
Reporting under it
Start here
Dates and penalties
Doing it
What you must file
Doing it
Start here
Setting targets
Who and where
The UK duty
Doing it
The baseline
Europe
Reporting more widely
Carbon markets and trade
Packaging and net zero
Carbon accounting
Choosing
Carbon
Compliance and offsets
Software
Templates
Careers
SBTi company profile · UK
Pharmaceuticals, Biotechnology and Life Sciences SME
Validated Targets
Data: Science Based Targets initiative Target Dashboard, as at 2026-10-08
Published records
The records below are reproduced from the Science Based Targets initiative Target Dashboard. A validated target is not evidence that emissions have fallen; progress requires the company’s reported emissions.
Target · Near-term · 1+2 — Other
2023 → 2030 · 1.5°C · published 2025-05-01
Mologic Ltd, trading as Global Access Diagnostics commits to reduce scope 1 and scope 2 GHG emissions 42% by 2030 from a 2023 base year, and to measure and reduce its scope 3 emissions.
Target · Net-zero · 1+2+3 — Other
2023 → 2050 · 1.5°C · published 2025-05-01
Mologic Ltd, trading as Global Access Diagnostics commits to reach net-zero by 2050.
Target · Long-term · 1+2+3 — Other
2023 → 2050 · 1.5°C · published 2025-05-01
Mologic Ltd, trading as Global Access Diagnostics commits to reduce scope 1+2+3 emissions 90% by 2050 from a 2023 base year.